Our early coverage of Xphyto reveals the following company trait: Xphyto says, “We’re going to do this” – and then they do it – quickly….
Dravet syndrome
Vektor is now proceeding with process implementation for the manufacture of Rotigotine patches for human clinical studies….
XPHY owns a German narcotic manufacturer called Vektor Pharma, another subsidiary called Bunker that has all the licenses to study cannabis as a medicine, and it has formed multiple…
Xphyto Therapeutics (XPHY.C) announced today that they advancing its thin film CBD delivery system for epilepsy sufferers to clinical trials. In the past three months, the company’s German subsidiary,…